EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland

Timea-Chiara Annovazzi, Jens Kuhle, Pascal Benkert, Sabine Schaedelin, Joelle Schwarz, Enriqueta Vallejo-Yagüe, Carole Clair, Caroline Pot

Frontiers in Neuroscience · 08.04.2026 · 20

DOI: 10.3389/fnins.2026.1745599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Neuroscience, online erschienen am 08.04.2026. Verfasst von Timea-Chiara Annovazzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health and Gender Unit, University Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There has been growing recognition of potential differences in disease course and presentation between men and women with MS. This study examined sex differences in MS using data collected at study entry in the Swiss Multiple Sclerosis Cohort (SMSC).

Methods

A cross-sectional analysis of the data from 1541 SMSC participants (June 2012–February 2022) with persons with relapsing-remitting MS or Clinically Isolated Syndrome (named relapsing type) and progressive MS including persons with Primary Progressive Multiple Sclerosis (PPMS) and Secondary Progressive Multiple Sclerosis (SPMS) was performed. Sociodemographic and clinical characteristics, disease history, and severity indicators were examined, focusing on sex differences within progressive and relapsing MS types, and comparing these MS types. Statistical analyses included Mann-Whitney U tests and chi-squared tests for group comparisons. Multivariate linear regression models were constructed to examine the independent association of sex with Expanded Disability Status Scale (EDSS) scores, adjusting for age, disease duration, treatment category, recent relapse, and body mass index (BMI).

Results

Women represented 65.8% of the cohort (1,014/1,541). BMI was significantly lower in women than in men in the relapsing type and SPMS (relapsing: p < 0.001; SPMS: p = 0.001; PPMS: p = 0.86). Age at first symptoms differed by sex depending on MS type: women were younger in the relapsing group (29.7 vs. 31.4 years, p = 0.036), while men were younger in PPMS (42.3 vs. 47.7 years, p < 0.001), with no difference in SPMS ( p = 0.5). In univariate analysis, men showed a trend toward higher disability levels at study entry in the relapsing type ( p = 0.058), but no significant sex differences in EDSS were observed in progressive forms. In multivariate analysis, female sex showed a trend toward lower EDSS scores in relapsing MS after adjusting for clinical factors (β = −0.13, 95% CI: −0.26 to 0.005, p = 0.059) but was not associated with EDSS in PPMS (β = −0.09, p = 0.802) or SPMS (β = + 0.09, p = 0.816).

Conclusion

This study identified sex differences in disease distribution, BMI and EDSS at their entry in the SMSC. These findings underscore the complexity of sex differences in MS and highlight the importance of prospective longitudinal studies with standardized severity assessments to clarify sex-specific disease trajectories and inform personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

Expanded Disability Status Scale (EDSS)body mass indexcross-sectional studydisabilitydisease progressiongender differencesmultiple sclerosisneurodegeneration

Autor:innen und Institutionen

  • Health and Gender Unit, University Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
  • Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Neurology, Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switz…
  • Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
  • Service of Neurology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Zitieren

APA

Annovazzi, T. C., Kuhle, J., Benkert, P., Schaedelin, S., Schwarz, J., Vallejo-Yagüe, E., Clair, C., & Pot, C. (2026). Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland. Frontiers in Neuroscience, 20. https://doi.org/10.3389/fnins.2026.1745599

Vancouver

Annovazzi TC, Kuhle J, Benkert P, Schaedelin S, Schwarz J, Vallejo-Yagüe E, et al. Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland. Frontiers in Neuroscience. 2026;20. doi:10.3389/fnins.2026.1745599

BibTeX
@article{Annovazzi2026,
  author = {Annovazzi, Timea-Chiara and Kuhle, Jens and Benkert, Pascal and Schaedelin, Sabine and Schwarz, Joelle and Vallejo-Yagüe, Enriqueta and Clair, Carole and Pot, Caroline},
  title = {Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland},
  journal = {Frontiers in Neuroscience},
  year = {2026},
  volume = {20},
  doi = {10.3389/fnins.2026.1745599}
}
Kostenlos starten →